Background: We sought to investigate the prognostic value of complete blood count (CBC)-based biomarkers for patients with resectable gastric cancer (GC).
Methods: Patients with GC who underwent primary surgical resection between December 2008 and December 2013 were included. The estimated area under the curve (AUC) and multivariate Cox regression models were used to identify the best CBC-based biomarker. Time-dependent receiver operating characteristic (t-ROC) curve analysis was used to predict overall survival and compare the prognostic impact.
Results: In the 1810 patients analyzed, the median follow-up period was 51.0 months (range 1-101 months). Based on multivariate analysis, the lymphocyte-monocyte ratio (LMR) and hemoglobin (Hb) level were independent prognostic factors (both P < 0.05). Based on the LMR and Hb level, we established the CBC-based inflammatory score (CBCS). A higher CBCS was associated with older age, female sex, higher American Society of Anesthesiologists (ASA) score, proximal tumor location, larger tumor size, later stage and vascular involvement (all P < 0.05). Univariate analyses showed that a higher CBCS was also associated with worse overall survival (OS), which was consistent in each stage (all P < 0.05). Multivariate analysis revealed that the CBCS was a significant independent biomarker (P < 0.05). The AUC for the CBCS (0.627) was significantly higher than the AUCs for the LMR (0.573) and Hb level (0.605) (both P < 0.05). Furthermore, the t-ROC curve of the CBCS was superior to that of the prognostic nutritional index (PNI), systemic immune-inflammation index (SII), modified Glasgow prognostic score (mGPS) and C-reactive protein/albumin ratio (CRP/Alb) throughout the observation period.
Conclusion: The preoperative LMR and Hb level were optimal CBC-based biomarkers for predicting OS in GC patients after curative resection. Based on the LMR and Hb, we developed a novel and easily obtainable prognostic score called the CBCS, which may improve the prediction of clinical outcomes.
Keywords: Biomarker; Complete blood count; Gastric cancer; Prognosis.
Conflict of interest statement
There are no conflicts of interest or financial ties to disclose for any of the authors.
Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.Gastric Cancer. 2019 Mar;22(2):403-412. doi: 10.1007/s10120-018-0854-6. Epub 2018 Jul 7. Gastric Cancer. 2019. PMID: 29982861
The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.J Endourol. 2019 Jan;33(1):1-8. doi: 10.1089/end.2018.0632. Epub 2018 Dec 26. J Endourol. 2019. PMID: 30430854
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.Chin J Cancer. 2017 Dec 21;36(1):96. doi: 10.1186/s40880-017-0260-1. Chin J Cancer. 2017. PMID: 29268783 Free PMC article.
Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.World J Gastroenterol. 2015 Oct 14;21(38):10898-906. doi: 10.3748/wjg.v21.i38.10898. World J Gastroenterol. 2015. PMID: 26478681 Free PMC article.
Preoperative Hematocrit (HCT) is a Novel and Simple Predictive Marker for Gastric Cancer Patients Who Underwent Radical Gastrectomy.Ann Surg Oncol. 2019 Nov;26(12):4027-4036. doi: 10.1245/s10434-019-07582-7. Epub 2019 Aug 28. Ann Surg Oncol. 2019. PMID: 31463693